Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

Treatment of Hepatitis B in Resource-limited Settings - a Pilot Program in East Africa

ID
Name
2014/1146
Description
Viral hepatitis kills nearly one million people each year, even though effective treatment exists. The aim of this study is to establish a treatment protocol for hepatitis B, which is simple and cheap enough to be implemented in resource-limited settings.
Trial arms
Trial start
2015-01-01
Estimated PCD
2024-12-01
Trial end
2024-12-01
Status
Active (not recruiting)
Treatment
Tenofovir disoproxil
Arms:
Rural, Urban
Size
1350
Primary endpoint
Death, HCC or decompensated cirrhosis
3 years
Eligibility criteria
Inclusion Criteria: * Consenting adults (≥18 years) residing in Ethiopia who are HBsAg positive Exclusion Criteria: * Children \<18 years, other terminal disease (cancer etc.)
Protocol
{'studyType': 'OBSERVATIONAL', 'patientRegistry': False, 'designInfo': {'observationalModel': 'COHORT', 'timePerspective': 'PROSPECTIVE'}, 'enrollmentInfo': {'count': 1350, 'type': 'ACTUAL'}}
Updated at
2023-11-01

1 organization

1 product

1 indication

Organization
Oslo University Hospital
Product
Tenofovir disoproxil
Indication
Hepatitis B